Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Double-blind, multicenter, randomized trial to compare the effect of two doses of adrenocorticotropic hormone versus placebo in controlling delayed emesis after high-dose cisplatin in adult patients with cancer.
Passalacqua R, Cocconi G, Caminiti C, Silingardi V, Bella MA, Bichisao E, Michiara M, Malavasi V, Donati D, Di Costanzo F, Rocca A, Di Sarra S, Scaglione F, Fraschini F. Passalacqua R, et al. Among authors: donati d. J Clin Oncol. 1997 Jun;15(6):2467-73. doi: 10.1200/JCO.1997.15.6.2467. J Clin Oncol. 1997. PMID: 9196163 Clinical Trial.
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
Roila F, Tonato M, Basurto C, Bella M, Passalacqua R, Morsia D, DiCostanzo F, Donati D, Ballatori E, Tognoni G, et al. Roila F, et al. Among authors: donati d. J Clin Oncol. 1987 Jan;5(1):141-9. doi: 10.1200/JCO.1987.5.1.141. J Clin Oncol. 1987. PMID: 3543234 Clinical Trial.
Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
Roila F, Tonato M, Basurto C, Picciafuoco M, Bracarda S, Donati D, Malacarne P, Monici L, Di Costanzo F, Patoia L, et al. Roila F, et al. Among authors: donati d. J Clin Oncol. 1989 Nov;7(11):1693-700. doi: 10.1200/JCO.1989.7.11.1693. J Clin Oncol. 1989. PMID: 2681556 Clinical Trial.
High-dose folinic acid and fluorouracil with or without ifosfamide is an inactive combination in advanced pancreatic cancer. A randomized phase II study of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Di Costanzo F, Tagliaventi M, Carlini P, Zironi S, Mazzocchi B, Bella M, Donati D, Acito L, Maggian P, Angiona S. Di Costanzo F, et al. Among authors: donati d. Am J Clin Oncol. 1996 Jun;19(3):307-10. doi: 10.1097/00000421-199606000-00021. Am J Clin Oncol. 1996. PMID: 8638548 Clinical Trial.
A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy.
Contu A, Olmeo N, Piro S, Sabbatini R, Depenni R, Silingardi V, Zaniboni A, Meriggi F, Donati D, Maestri A, et al. Contu A, et al. Among authors: donati d. Anticancer Drugs. 1995 Oct;6(5):652-6. doi: 10.1097/00001813-199510000-00004. Anticancer Drugs. 1995. PMID: 8845475 Clinical Trial.
Intravenous itasetron: establishing the effective dose range for the prophylactic control of acute emesis in cancer patients undergoing high-dose cisplatin chemotherapy.
Patoia L, Del Favero A, Giglietti A, Malacarne P, Donati D, Indelli M, Bensi G, Palladino MA, Cigarini P, Kempe R, Voigt T. Patoia L, et al. Among authors: donati d. Clin Oncol (R Coll Radiol). 1999;11(2):99-104. doi: 10.1053/clon.1999.9022. Clin Oncol (R Coll Radiol). 1999. PMID: 10378635 Clinical Trial.
634 results